Stopping blood thinners with a left-atrial device in bleeding risk
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether it’s safe to temporarily stop blood-thinning medicine in people with long-term atrial fibrillation who have bleeding from a radiation-damaged bladder. It uses a procedure with a device placed in the left atrium to help lower stroke risk while reducing bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and covered by a social security health plan
- You have non-valvular atrial fibrillation (a common heart rhythm problem)
- You take an anticoagulant (a blood thinner) for atrial fibrillation
- You have blood in the urine (hematuria) caused by radiation bladder injury
- The bleeding must be from radiation bladder injury, not from another cause
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether closing a heart pocket called the left atrial appendage can lower future stroke or other clot-related events in people with atrial fibrillation. It’s mainly for people who have had a prior clot-related event or are at higher risk but may not be good candidates for long-term blood thinners.
This trial tests whether it is safe to stop taking blood thinners (anticoagulants) after a successful ablation procedure for atrial fibrillation. If you have had no AF for 3 months after your first ablation, you may be able to stop these medications, reducing your risk of bleeding.
This trial tests whether it is safe for patients with atrial fibrillation to stop taking blood thinners after they have had heart surgery, including closure of the left atrial appendage. The goal is to see if these patients can avoid long-term medication without increasing the risk of stroke.
This trial compares which two medicines work best after a device closes off a part of the heart called the left atrial appendage. It may help reduce stroke risk while balancing bleeding risk after your procedure.
This trial looks at the best blood-thinning (antiplatelet) plan after a left atrial appendage closure procedure in people with kidney failure on dialysis. It may help reduce stroke risk while also lowering medicine-related side effects.
This Phase 3 trial studies whether it’s safer to avoid long-term blood thinners after a spontaneous brain bleed in people with atrial fibrillation (an irregular heart rhythm). It compares different prevention strategies to lower the risk of stroke or other blood-vessel problems without causing new, serious bleeding.
Hear when a new Radiation Cystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.